Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 2.36Cr 2.05Cr 1.91Cr 1.76Cr 3.32Cr 224.73Cr 3.36Cr 23Cr 8.81Cr 112.34Cr 8.87Cr 8.68Cr 372.22Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.66Cr 3.42Cr 3.14Cr 5.93Cr 401.27Cr 6Cr 40Cr 16Cr 200.59Cr 16Cr 15Cr 664.64Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-20.71%-19.80% - - 13.34L
+2.18%+5.60%+35.65%+453.51% 232.52Cr
+9.81%+24.34%-20.34%-48.35% 195.51Cr
-1.47%-0.49% - - 185.44Cr
+1.59%+1.73%+95.19%+413.24% 136.87Cr
0.00%-1.35%-46.92%+33.33% 124.44Cr
-0.25%-0.87%+328.63%+911.72% 109.96Cr
+5.01%+6.83%+65.61%+49.65% 106.17Cr
-2.56%+13.84%+20.52%+65.01% 89Cr
+10.04%+77.19%+80.46%-16.15% 64Cr
Average +0.40%+10.02%+69.85%+232.74% 138.2Cr
Weighted average by Cap. +2.68%+8.05%+58.16%+252.29%

Financials

2015 2016
Net sales 2.55Cr 2.21Cr 2.06Cr 1.9Cr 3.58Cr 242.38Cr 3.62Cr 24Cr 9.51Cr 121.16Cr 9.57Cr 9.36Cr 401.47Cr 3.23Cr 2.81Cr 2.62Cr 2.4Cr 4.55Cr 307.53Cr 4.6Cr 31Cr 12Cr 153.73Cr 12Cr 12Cr 509.37Cr
Net income 54.95L 47.71L 44.48L 40.87L 77.29L 52Cr 78.13L 5.24Cr 2.05Cr 26Cr 2.06Cr 2.02Cr 87Cr 20.61L 17.9L 16.69L 15.33L 28.99L 20Cr 29.31L 1.97Cr 76.91L 9.8Cr 77.41L 75.71L 32Cr
Net Debt 2.48Cr 2.15Cr 2.01Cr 1.84Cr 3.49Cr 235.95Cr 3.53Cr 24Cr 9.26Cr 117.95Cr 9.31Cr 9.11Cr 390.81Cr 1.86Cr 1.61Cr 1.5Cr 1.38Cr 2.61Cr 176.55Cr 2.64Cr 18Cr 6.93Cr 88Cr 6.97Cr 6.82Cr 292.42Cr
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-